Prospective studies with oligometastases
of
Lung
treated with
SBRT
Oligo metastases: new paradigm and options for radiotherapy
SBRT:
•
2 Years local control rates of
50-~ 90-96% / Survival 40-84%
•
Limited Toxicity; Mostly not grade 3-4
•
Contra indications for SBRT are limited
SBRT
in lung metastases is a good alternative for metastasectomy
Badakhshi et al




